Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TCL1 is activated by chromosomal rearrangement or by hypomethylation

1 Jan 2001

Abstract excerpt

TCL1 is an oncogene activated by recurrent reciprocal translocations at chromosome segment 14q32.1 in the most common of the mature T-cell malignancies, T-cell prolymphocytic leukemia. It acts to transport Akt1 to the nucleus and enhance Akt1's serine-threonine kinase activity. TCL1 is also expressed in the B-cell malignancy, Burkitt's lymphoma (BL). However, 14q32.1 breakpoints have not been detected in BL, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Chronic Lymphocytic Leukemia Research
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11241786
DOI: 10.1002/gcc.1099

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TCL1 is activated by chromosomal rearrangement or by hypomethylationPMID 11241786Read ↗

Molecular Basis of Mature T-Cell LeukemiaSemantic proximity Read ↗

Abnormalities at 14q32.1 in T cell malignancies involve two oncogenesSemantic proximity Read ↗

Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL)Semantic proximity Read ↗

Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by <i>miR-29</i> and <i>miR-181</i>Semantic proximity Read ↗

Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL.Semantic proximity Read ↗

Deregulated expression of TCL1 causes T cell leukemia in miceSemantic proximity Read ↗

<i>TCL1</i> targeting <i>miR-3676</i> is codeleted with tumor protein p53 in chronic lymphocytic leukemiaSemantic proximity Read ↗

Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaSemantic proximity Read ↗

Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies.Semantic proximity Read ↗

Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignanciesSemantic proximity Read ↗

Tcl1 enhances Akt kinase activity and mediates its nuclear translocationSemantic proximity Read ↗

T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.